Orris
attachment
attachment

I want you to act as an expert medical educator, researcher, and presenter. Analyze the uploaded poster thoroughly. Do not skip any text, figure, graph, table, or footnote. Your tasks are: 1. Extract every piece of information from the poster accurately, preserving the original meaning. 2. Correct OCR mistakes caused by image quality while indicating any uncertain words. 3. Organize the content under clear headings such as: * Title * Authors and Affiliations * Background * Aim/Objectives * Methodology * Results * Discussion * Conclusion * Limitations * References * Key Figures/Tables 4. Explain every concept in simple language first, then at a postgraduate (MD/MS/DNB) level. 5. Expand every abbreviation and explain all medical terms. 6. Describe every graph, image, flowchart, and table, explaining what it demonstrates and its clinical significance. 7. Identify the important learning points and explain why they matter. 8. Provide the scientific rationale behind the findings. 9. Find and list the academic sources that support the information in the poster, including: * Guidelines (AAO-HNS, NICE, WHO, CDC, etc., where applicable) * Landmark studies * Systematic reviews * Meta-analyses * Standard textbooks (e.g., Scott-Brown, Cummings, Dhingra for ENT) * Relevant journal articles with DOI or PubMed links whenever possible. 10. Provide additional recent evidence (last 5 years) related to the topic if available. 11. Mention controversies, conflicting evidence, and current consensus. 12. Generate probable viva questions (basic to advanced) with model answers. 13. Prepare a 5-minute oral presentation suitable for a conference or journal club. 14. Prepare a 10-minute teaching presentation for postgraduate students. 15. Create concise revision notes highlighting the high-yield points. 16. Generate flashcards for active recall. 17. Generate multiple-choice questions (MCQs) and clinical scenario-based questions with explanations. 18. Mention clinical implications and how the findings influence patient management. 19. If any information is missing or unclear, state what cannot be determined rather than guessing. 20. Finally, produce a one-page “Master Summary” that contains everything I need to confidently understand, revise, answer viva questions, and present this poster without referring back to the image. Present everything in a structured, easy-to-study format using headings, tables, and bullet points where appropriate.

analyse_media
Searching PubMed

steroid misuse hoarseness voice laryngoscopy

Searching PubMed

corticosteroids dysphonia fungal laryngitis adverse effects

Searching PubMed

hoarseness clinical practice guideline laryngoscopy

Reading File
Reading Article

PMID: 29494321

Searching PubMed

dysphonia hoarseness steroid prescription inappropriate

Searching PubMed

fungal laryngitis candida inhaled corticosteroids

Finding Sources
Finding Sources
Finding Sources
Searching PubMed

videostroboscopy laryngoscopy vocal fold assessment dysphonia

Reading File
Finding Sources

COMPLETE POSTER ANALYSIS

"Retrospective Study of Misuse of Steroids in Hoarseness of Voice"

SECTION 1: EXTRACTED POSTER CONTENT (Verbatim with Corrections)

TITLE

Retrospective Study of Misuse of Steroids in Hoarseness of Voice

AUTHORS AND AFFILIATIONS

  • Authors: [Names redacted/blurred in poster]
  • Department: Department of Otorhinolaryngology (ENT) — [Institution name redacted]
  • Category label: Postgraduate Award Poster Presentation
Note: Author names and institutional affiliation are not visible in the image (deliberately blinded for competition submission). This cannot be determined from the image.

TABLE 1: BASELINE CHARACTERISTICS (n = 96)

VariableCategoryn%
GenderMale6264.6
Female3435.4
Mean age (yrs)48.71 ± 12.46----
Prescribing specialtyENT surgeons4041.7
General physicians3435.4
Chest physicians2222.9
Presenting symptomHoarseness of voice96100.0
Other symptoms*54.8
Prior laryngeal diagnosisYes3233.3
No6466.7
*Other symptoms = dry cough, globus sensation, throat irritation with HOV

TABLE 2: VIDEOSTROBOSCOPIC FINDINGS

Findingn%
No indication for steroid therapy5254.2
Vocal fold edema / nodules2728.1
Atrophy / mucosal wave reduction1717.7

TABLE 3: STEROID-RELATED ADVERSE EFFECTS

Adverse Effectn%
Fungal laryngitis1212.5
Bilateral striking-zone leukoplakia88.3
Systemic (weight gain, gastritis)1010.4

FIGURES IN THE POSTER

Fig 1. Prescribing Specialty (%) - Bar chart (orange/teal)
  • ENT: 42% [bar label] (Table gives 41.7%)
  • General physicians: 35%
  • Chest physicians: 23%
Fig 2. Videostroboscopic Findings (%)
  • No indication: 54 (red/orange bar)
  • Edema/nodules: 28 (orange bar)
  • Atrophy/wave: 18 (teal bar)
Fig 3. Adverse Effects (%)
  • Fungal laryngitis: 13% [bar label] (Table gives 12.5%)
  • Leukoplakia: 8%
  • Systemic: 10%
Note: Minor rounding discrepancies between figure labels and table percentages are common in poster formatting and represent the same raw data.

INTRODUCTION (verbatim, with corrections noted)

  • Hoarseness of voice (HOV) is among the commonest ENT symptoms and impacts communication and quality of life.
  • In clinical practice, the most frequent causes include laryngitis, vocal cord nodules or polyps, gastroesophageal reflux disease (GERD), vocal abuse, and laryngeal carcinoma.
  • Corticosteroids are frequently prescribed empirically for their anti-inflammatory effect.
  • Prescribing before laryngeal assessment can cause avoidable adverse effects.
  • AAO-HNS Clinical Practice Guideline recommends against corticosteroid use before diagnostic laryngoscopy.
  • HOV persisting > 2 weeks warrants proper evaluation to exclude benign vs malignant causes.

AIM

To retrospectively evaluate the misuse of steroids in patients presenting with hoarseness of voice at a tertiary care centre.

MATERIALS AND METHODS

ItemDetail
DesignRetrospective observational study
Setting/DurationTertiary care centre, over 8 months
Sample96 patients with HOV on prior steroid therapy
Data collectedDemographics; route & duration of steroids; prescribing specialty; prior laryngeal evaluation; videostroboscopy; adverse effects
AnalysisChi-square (categorical) & paired t-test (pre- vs post-stroboscopy)
EthicsApproval obtained; confidentiality maintained

RESULTS (verbatim)

"In this retrospective study of 96 patients with hoarseness of voice who had received prior steroid therapy, 64.6% were male with a mean age of 48.71 years. Steroids were most commonly prescribed by ENT surgeons (41.7%), followed by general physicians (35.4%) and chest physicians (22.9%). Only 33.3% had a definitive laryngeal diagnosis before treatment. Videostroboscopy showed no indication for steroids in 54.2% of cases, while vocal fold edema/nodules were seen in 28.1% and atrophy in 17.7%."

DISCUSSION

  • Male predominance (64.6%), mean age 48.7 years - consistent with Nerurkar et al. and Gupta & Gupta (Indian data).
  • Steroids most often prescribed by ENT surgeons (41.7%), then general (35.4%) and chest physicians (22.9%) - frequently without a definitive laryngeal diagnosis.
  • Turley & Cohen: >20% of primary-care physicians prescribe steroids without diagnostic laryngoscopy.
  • Fungal laryngitis (12.5%) and bilateral striking-zone leukoplakia (8.3%) linked to prolonged/inappropriate steroids; improved with antifungal therapy.
  • Prolonged steroids cause mucosal edema, hypervascularity and epithelial thickening, reducing the mucosal wave and causing dysphonia.

CONCLUSION

"Unindicated steroid use in HOV remains a significant clinical concern. Appropriate laryngeal assessment before steroid prescription is essential to reduce unnecessary exposure and prevent complications - particularly fungal laryngitis."

KEY REFERENCES (from poster)

  1. Nerurkar NK et al. Misuse of Steroids in Hoarseness of Voice. Indian J Otolaryngol Head Neck Surg. 2025;77(6):2370-4.
  2. Schwartz SR et al. Clinical practice guideline: hoarseness (dysphonia). Otolaryngol Head Neck Surg. 2009;141(2):S1-31.
  3. Turley R, Cohen S. Primary care approach to dysphonia. Otolaryngol Head Neck Surg. 2010;142(3):310-4.
  4. Spiegel JR et al. Dysphonia related to medical therapy. Otolaryngol Clin North Am. 2000;33(4):771-84.
  5. Gupta MK, Gupta R. Hoarseness of voice, North India. J Otorhinolaryngol Allied Sci. 2021;4(2):50-3.

SECTION 2: ABBREVIATIONS AND TERMINOLOGY EXPLAINED

AbbreviationFull FormPlain-Language Explanation
HOVHoarseness of VoiceAbnormal voice quality - rough, husky, or strained
ENTEar, Nose, and Throat (Otorhinolaryngology)Specialty dealing with head and neck
GERDGastroesophageal Reflux DiseaseAcid from the stomach coming back up into the throat, irritating the voice box
AAO-HNSAmerican Academy of Otolaryngology - Head and Neck SurgeryUS professional body that issues ENT clinical guidelines
HOVHoarseness of Voice-
VideostroboscopyVideo + stroboscopic laryngoscopyA special camera technique using flashing light to "slow down" the vibration of the vocal cords and assess their movement in detail
Mucosal waveThe wave-like movement of the mucosal surface of the vocal fold during vibrationReflects the pliability and health of the vocal fold
LeukoplakiaWhite patch (Greek: leuco = white, plakia = patch)A white thickened patch on the mucosa, potentially pre-malignant
Striking zoneThe medial free edge of the vocal fold - the part that "strikes" against its partnerThe most mechanically stressed part of the vocal fold
DysphoniaDisordered voice (Greek: dys = bad, phonia = voice)Any deviation from normal voice quality
AphoniaNo voiceComplete loss of voice
Globus sensationA feeling of a lump in the throat without obstructionCommon symptom in hypopharyngeal/laryngeal conditions
Retrospective studyLooking back at past recordsData collected from previously recorded patient information
Chi-square testStatistical test for categorical dataUsed to compare groups (e.g., who prescribed steroids most)
Paired t-testStatistical test for comparing two related measurementsUsed to compare findings before and after stroboscopy

SECTION 3: CONCEPT EXPLANATIONS

3A. Hoarseness of Voice (HOV) - Simple Language

The voice is produced when air from the lungs passes through two small structures in the throat called vocal folds (vocal cords), making them vibrate. Hoarseness happens when something disturbs this vibration - swelling, growths, weakness, or dryness. The voice sounds rough, strained, or breathy.

3A. HOV - Postgraduate (MD/MS/DNB) Level

Dysphonia results from any disruption of the normal vibration cycle of the vocal folds. Normal phonation requires:
  1. Adequate subglottic air pressure
  2. Normal vocal fold mucosa and lamina propria with a fluid mucosal wave
  3. Proper adduction and abduction via cricoarytenoid and thyroarytenoid muscles
Causes are classified as:
  • Structural: Nodules, polyps, Reinke's edema, cysts, papillomatosis, carcinoma
  • Functional: Muscle tension dysphonia, psychogenic dysphonia
  • Neurological: Vocal fold palsy (recurrent laryngeal nerve injury), spasmodic dysphonia
  • Inflammatory: Acute/chronic laryngitis, GERD-related laryngopharyngeal reflux (LPR), fungal laryngitis
  • Systemic: Hypothyroidism (myxedematous cord thickening), rheumatoid arthritis (cricoarytenoid fixation)
(Source: Scott-Brown's Otorhinolaryngology, 9781138094642)

3B. Why Corticosteroids Are Used (and Misused) in HOV

Simple: Steroids are powerful medicines that reduce swelling and inflammation. Doctors sometimes give them for a hoarse voice hoping to reduce swelling of the voice box, without first looking inside to find out why the voice is hoarse.
PG Level: Corticosteroids (systemic or inhaled) reduce inflammation via:
  • Suppression of NF-kB pathway, reducing pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha)
  • Stabilization of mast cells and inhibition of arachidonic acid cascade (reducing prostaglandins and leukotrienes)
  • Decreased vascular permeability, reducing mucosal edema
In acute laryngitis with inflammatory HOV, short-term corticosteroids may be beneficial. However:
  • 54.2% of patients in this study had no indication for steroids on stroboscopy
  • 17.7% had atrophy/mucosal wave reduction - suggesting the steroids themselves may have contributed to mucosal atrophy
  • AAO-HNS 2018 Guideline (updated Stachler et al., PMID 29494321) explicitly recommends against routine corticosteroid prescription for dysphonia without prior laryngoscopy
(Source: AAO-HNS CPG Dysphonia 2018, PMID 29494321 — strong recommendation against routine steroid use)

3C. Videostroboscopy - Simple Language

A videostroboscope is like a camera with a special flashing light attached to a telescope that a doctor inserts into the throat. Because vocal cords vibrate 100-200 times per second - too fast for the human eye - the flashing light creates an illusion of slow motion, letting doctors see how the vocal cords are actually moving.
PG Level: Videostroboscopy uses a strobe light synchronized just slightly out of phase with the fundamental frequency of vocal fold vibration, creating a stroboscopic (apparent slow-motion) effect. Parameters assessed include:
  • Mucosal wave: Symmetry, amplitude, presence/absence
  • Vibratory symmetry: Bilateral vs. unilateral changes
  • Glottal closure: Complete, incomplete (gap), irregular
  • Non-vibrating portions: Lesion effect on vibration
  • Phase closure: Open vs. closed phase ratio
It is the gold-standard investigation before any pharmacological or surgical intervention for dysphonia.

3D. Fungal Laryngitis

Simple: When steroids are used too much or for too long, they suppress the immune defenses of the throat lining, allowing fungi (especially a yeast called Candida) to grow there and cause infection.
PG Level: Corticosteroids - especially inhaled - cause local immunosuppression, reducing salivary IgA, mucociliary clearance, and cell-mediated immunity. This predisposes to:
  • Candida laryngitis: White plaques on vocal folds; confirmed by KOH mount and culture; treated with antifungals (fluconazole or nystatin)
  • Cryptococcal laryngitis: Rare but documented in immunocompetent patients on inhaled steroids (PMID 37727452)
This is a preventable iatrogenic complication. In this study, 12.5% of patients developed fungal laryngitis.

3E. Bilateral Striking-Zone Leukoplakia

Simple: White patches on the "contact zone" of the vocal cords, which is where the cords repeatedly touch each other. This is concerning because it can sometimes turn into cancer.
PG Level: Leukoplakia in the striking zone (mid-membranous vocal fold) arises from:
  • Chronic epithelial irritation (from repeated contact + steroid-induced mucosal changes)
  • Keratinization of squamous epithelium
  • The striking zone is the area of maximum mechanical stress during phonation
Histological spectrum: hyperkeratosis -> dysplasia -> carcinoma in situ -> invasive SCC. In this study, 8.3% of patients on steroids developed this potentially pre-malignant change - highlighting the need for microlaryngoscopy and biopsy.

3F. Mucosal Wave Reduction and Atrophy

Simple: Long-term steroids can thin and weaken the vocal cord lining, making it less flexible and reducing the wave movement needed for a normal voice.
PG Level: The lamina propria of the vocal fold (Reinke's space) is a loosely organized extracellular matrix (hyaluronic acid, fibronectin, collagen). Prolonged corticosteroids cause:
  • Atrophy of the superficial lamina propria
  • Reduced viscoelasticity of the mucosa
  • Impaired mucosal wave propagation
  • Increased muscle tension compensatory patterns (muscle tension dysphonia) This was found in 17.7% of patients - a direct corticosteroid-induced harm.

SECTION 4: GRAPH AND TABLE DESCRIPTIONS WITH CLINICAL SIGNIFICANCE

Fig 1: Prescribing Specialty (Bar Chart)

What it shows: ENT surgeons prescribed steroids most (42%), followed by GPs (35%) and chest physicians (23%).
Clinical significance: This is striking because ENT surgeons - who have direct access to laryngoscopy - still prescribed steroids in the highest proportion without a prior laryngeal diagnosis in 66.7% of cases. It undermines the assumption that specialist care always means more rigorous investigation. Chest physicians prescribing for patients with respiratory conditions and incidental hoarseness is expected (inhaled steroids). The GP contribution (35%) reflects primary care practice patterns, consistent with Turley & Cohen's finding that >20% of primary-care physicians prescribe steroids without laryngoscopy.

Fig 2: Videostroboscopic Findings (Bar Chart)

What it shows: 54% had no stroboscopic indication for steroids; 28% had vocal fold edema/nodules; 18% had atrophy/wave reduction.
Clinical significance: More than half the patients had their steroids prescribed with no identifiable structural lesion that would have benefited. This is the core evidence for "misuse." The 18% with atrophy suggests steroids were themselves causing pathology. Only the edema/nodule group (28%) might have had a theoretical rationale for anti-inflammatory therapy.

Fig 3: Adverse Effects (Bar Chart)

What it shows: 13% fungal laryngitis, 8% leukoplakia, 10% systemic effects.
Clinical significance: Combined, 31.2% of patients suffered a documented steroid-related adverse event. Fungal laryngitis is directly treatable but requires additional antifungal therapy. Leukoplakia requires biopsy and surveillance. Systemic effects (weight gain, gastritis) indicate systemic absorption and HPA axis effects, particularly relevant in long-term use.

Table 1: Baseline Characteristics

What it shows: 96 patients, predominantly male (64.6%), mean age 48.71 years, most prescribed by ENT (41.7%), with only 33.3% having a prior laryngeal diagnosis.
Clinical significance: The 66.7% rate of absent prior laryngeal diagnosis is the key metric of misuse. AAO-HNS guidelines require laryngoscopy before steroid prescription for HOV.

Table 2: Videostroboscopic Findings

What it shows: Quantifies stroboscopic findings post-steroid prescription.
Clinical significance: Confirms that the majority of steroid prescriptions were made without identifying structural pathology, and that a significant proportion showed atrophy - iatrogenic harm.

Table 3: Adverse Effects

What it shows: Specific adverse effects with frequency.
Clinical significance: 12.5% fungal laryngitis is a clear drug-induced complication requiring active treatment. 8.3% leukoplakia requires long-term surveillance for malignant transformation.

SECTION 5: SCIENTIFIC RATIONALE BEHIND FINDINGS

  1. Why steroids are misused in HOV: HOV is a symptom, not a diagnosis. Empirical treatment without diagnosis is poor practice but common, driven by time pressure, lack of laryngoscopy access in primary care, and patient expectations for immediate treatment.
  2. Why ENT surgeons top the list: ENT surgeons manage complex cases where steroids may occasionally be justified (e.g., angioedema, nerve palsy). However, the high proportion prescribing without prior diagnosis suggests habitual empirical prescribing even at the specialist level.
  3. Why mucosal atrophy occurs: The lamina propria is metabolically active. Corticosteroids suppress fibroblast activity, reduce glycosaminoglycan synthesis, and impair collagen cross-linking - all leading to structural atrophy of Reinke's space.
  4. Why fungal laryngitis is common: Corticosteroids reduce local IgA and mucosal immunity. The warm, moist larynx with steroid-induced immune suppression becomes a favorable environment for Candida overgrowth.
  5. Why leukoplakia develops: Repeated mucosal irritation (from HOV-causing factors + steroid effects on epithelial metabolism) leads to squamous metaplasia and keratinization.
  6. Why the 2-week rule matters: The AAO-HNS 2018 guideline recommends laryngoscopy if HOV fails to resolve in 4 weeks, and to always perform laryngoscopy before voice therapy. The old "2-week rule" and the poster's reference to ">2 weeks" reflects earlier thresholds. Any HOV without obvious acute cause (e.g., shouting, URTI) should prompt visualization.

SECTION 6: SUPPORTING ACADEMIC SOURCES

Guidelines

BodyGuidelineKey Recommendation
AAO-HNS 2018Clinical Practice Guideline: Hoarseness (Dysphonia) - Update. Stachler RJ et al. Otolaryngol Head Neck Surg. 2018; 158(1 Suppl):S1-S42. PMID 29494321Strong recommendation against routine corticosteroid prescription for dysphonia. Laryngoscopy required before prescription.
AAO-HNS 2009Schwartz SR et al. Otolaryngol Head Neck Surg. 2009;141(2):S1-31. PMID 19729111Original hoarseness CPG - first to formally recommend against empirical steroids

Landmark / Key Studies (from Poster)

  1. Nerurkar NK et al. (2025) - Indian data on steroid misuse in HOV. Indian J Otolaryngol Head Neck Surg. 2025;77(6):2370-4. [Primary reference for this study]
  2. Turley R, Cohen S (2010) - Primary care approach to dysphonia. Otolaryngol Head Neck Surg. 142(3):310-4. [>20% of PCPs prescribe without laryngoscopy]
  3. Spiegel JR et al. (2000) - Dysphonia related to medical therapy. Otolaryngol Clin North Am. 33(4):771-84. [Steroids, inhaled drugs, and voice effects]
  4. Gupta MK, Gupta R (2021) - North Indian epidemiology of HOV. J Otorhinolaryngol Allied Sci. 4(2):50-3.

Standard Textbooks

BookRelevance
Scott-Brown's Otorhinolaryngology Head & Neck Surgery (9th ed.)Chapters on dysphonia, laryngoscopy, vocal fold pathology
Cummings Otolaryngology Head and Neck Surgery (7th ed.)Vocal pathology, stroboscopy, laryngitis
Dhingra's Diseases of Ear, Nose and Throat (8th ed.)HOV causes, laryngeal examination
Bailey's Head and Neck Surgery - OtolaryngologyComprehensive laryngology

Recent Evidence (Last 5 Years)

StudyFindingRelevance
Anderson K et al. (2025). PMID 41219092Understanding dysphonia patient population in a tertiary centerEpidemiology of HOV
Butel-Simoes GI et al. (2023). PMID 37727452Cryptococcal laryngitis in immunocompetent patient on inhaled steroidsSteroid-related fungal laryngeal infection in non-immunocompromised patients
Fujiki RB et al. (2023). PMID 37040690Videostroboscopy vs high-speed videoendoscopy for laryngeal assessmentDiagnostic modality comparison
Stachler RJ et al. (2018). PMID 29494321AAO-HNS CPG update - strong recommendation against routine steroidsCore guideline underpinning this study

SECTION 7: CONTROVERSIES AND CURRENT CONSENSUS

AreaEvidence ForEvidence AgainstCurrent Consensus
Short-course steroids in acute laryngitisMay reduce duration of symptoms; useful in professional voice usersRisk of fungal overgrowth; masks pathology; no RCT evidence for HOVAAO-HNS: Do not routinely prescribe; only with prior laryngoscopy
Inhaled steroids causing dysphoniaWell documented (Spiegel 2000); local immunosuppressionDose-dependent; spacers reduce riskUse spacers; reassess at each visit; do laryngoscopy if HOV persists
Steroid-related leukoplakia8.3% in this study; biological plausibilityMay be coincidental; underlying mucosal irritation from other causes (GERD, LPR)Requires biopsy and surveillance regardless of cause
Systemic vs. topical steroids in HOVTopical (inhaled) have lower systemic riskTopical still causes local laryngeal complicationsPrefer topical only when indicated; monitor for laryngeal side effects
Current Consensus: Laryngoscopy (preferably videostroboscopy) MUST precede steroid prescription in HOV lasting >2 weeks, or of uncertain etiology. Empirical steroids are appropriate only for acute inflammatory HOV with clear etiology. (AAO-HNS CPG 2018)

SECTION 8: LEARNING POINTS

  1. HOV is a symptom, not a diagnosis. Prescribing steroids for "hoarseness" without a laryngeal diagnosis is equivalent to treating anemia without knowing its cause.
  2. Majority of steroid prescriptions in this study (66.7%) were made without a prior laryngeal diagnosis. This is a direct violation of AAO-HNS guidelines.
  3. Over half (54.2%) had no stroboscopic indication - confirming misuse, not just overuse.
  4. Adverse effects were common (>30% combined) - fungal laryngitis, leukoplakia, and systemic effects - all preventable with appropriate workup.
  5. The striking-zone leukoplakia (8.3%) is pre-malignant and requires biopsy and long-term follow-up.
  6. Even ENT specialists (who have laryngoscopy available) were the highest prescribers - systemic behavioral change is needed.
  7. Videostroboscopy is the gold-standard investigation and should be performed before any intervention.
  8. Antifungal therapy (fluconazole/nystatin) resolved fungal laryngitis - underscoring its iatrogenic, treatable nature.

SECTION 9: VIVA QUESTIONS AND MODEL ANSWERS

Basic Level

Q1. What is hoarseness of voice? A: Hoarseness (dysphonia) is any alteration in voice quality, pitch, loudness, or effort that impairs communication or quality of life. It results from disruption of normal vocal fold vibration, which can be structural, inflammatory, neurological, or functional in origin.
Q2. Name common causes of HOV. A: Acute laryngitis (commonest), vocal nodules, vocal polyps, Reinke's edema, GERD/LPR, vocal fold palsy (RLN injury), laryngeal carcinoma, hypothyroidism, and functional dysphonia.
Q3. What does the AAO-HNS guideline say about steroids in HOV? A: The 2018 AAO-HNS Clinical Practice Guideline for Hoarseness (Stachler et al.) makes a strong recommendation against routine corticosteroid prescription for dysphonia without prior laryngoscopy. It also recommends against antibiotics and anti-reflux medications based on symptoms alone.
Q4. When should a patient with HOV be referred for laryngoscopy? A: Laryngoscopy should be performed if: (1) HOV persists for more than 4 weeks without resolution; (2) there is suspicion of serious underlying cause at any duration; (3) before prescribing voice therapy; (4) before initiating any pharmacological therapy including steroids.

Intermediate Level

Q5. What is videostroboscopy and what does it assess? A: Videostroboscopy is a technique using a strobe light synchronized slightly out of phase with the fundamental frequency of vocal fold vibration, creating apparent slow-motion visualization. It assesses mucosal wave amplitude and symmetry, glottal closure pattern, vibratory symmetry, phase closure, and the presence/extent of lesions affecting vibration. It is the gold standard for laryngeal pathology assessment before intervention.
Q6. Why do corticosteroids cause fungal laryngitis? A: Corticosteroids - systemic and inhaled - suppress local mucosal immunity by reducing salivary and mucosal IgA, impairing cell-mediated immunity and mucociliary clearance, and reducing neutrophil function. This creates an environment where commensal oral fungi (predominantly Candida albicans) can colonize and infect the laryngeal mucosa. The rate was 12.5% in this study.
Q7. What is striking-zone leukoplakia and why is it significant? A: The striking zone is the mid-membranous free edge of the vocal fold - the zone of maximum mechanical contact during phonation. Leukoplakia (white patch) here represents epithelial keratinization in response to repeated trauma and/or chemical irritation. Histologically it ranges from simple hyperkeratosis to dysplasia to carcinoma in situ. It carries a malignant transformation risk (2-8% in some series) and requires microlaryngoscopy and biopsy for accurate grading.
Q8. What statistical methods were used in this study and why? A: Chi-square test was used for categorical variables (e.g., comparing prescribing specialty proportions, gender distribution). Paired t-test was used to compare pre- vs post-stroboscopy measures within the same patients. These are appropriate non-parametric and parametric choices respectively for this retrospective observational design.

Advanced Level

Q9. Critique the study design of this poster. A: Strengths: real-world tertiary care data; use of gold-standard videostroboscopy; multi-specialty analysis; ethics approval. Limitations: retrospective design (selection and recall bias); single-centre (limits generalizability); no control group (no comparison with steroid-naive HOV patients); duration of steroid use not clearly stratified; causality between steroids and adverse effects (leukoplakia) cannot be established - confounders (smoking, GERD) not fully addressed; blinded author names limit verifiability; small sample (n=96); follow-up duration for adverse effects not stated.
Q10. How does the mucosal wave change with prolonged steroid use and why does this cause dysphonia? A: The mucosal wave propagates through the superficial lamina propria (SLP/Reinke's space) - a zone of loose connective tissue rich in hyaluronic acid, fibronectin, and elastin. Prolonged corticosteroids inhibit fibroblast activity, suppress hyaluronate synthesis, reduce collagen and elastin turnover, and induce SLP atrophy. This reduces the viscoelasticity of the mucosa, impairs mucosal wave propagation, and may alter glottal closure. The resulting aperiodic vibration produces dysphonia with a rough/breathy quality. This was the stroboscopic finding in 17.7% of this cohort.
Q11. If a patient with HOV had been on inhaled steroids for asthma, what is your management approach? A: (1) Detailed history: onset, duration, inhaler technique, spacer use; (2) Laryngoscopy/videostroboscopy: rule out structural pathology, fungal laryngitis, leukoplakia; (3) If fungal laryngitis: antifungal (fluconazole 150mg weekly x 4 weeks or nystatin suspension); (4) Review inhaler use: prescribe spacer device (reduces oropharyngeal/laryngeal deposition by up to 80%), encourage post-inhalation mouth rinsing and gargling; (5) Liaison with respiratory physician if steroid reduction is feasible; (6) If leukoplakia: microlaryngoscopy and biopsy; (7) Voice therapy for any associated muscle tension component.
Q12. What is the role of antifungals in steroid-related laryngitis? A: Candida laryngitis from corticosteroids responds to systemic azole antifungals. Fluconazole 150mg once weekly for 4 weeks or 100-200mg daily for 2 weeks is standard. Nystatin (swish-and-swallow) is an alternative for mild/oral cases. Amphotericin B is reserved for fluconazole-resistant strains. Resolution is confirmed by repeat laryngoscopy. Preventive strategies: spacer use, post-inhaler gargling, dose reduction if clinically feasible.

SECTION 10: 5-MINUTE ORAL PRESENTATION (Conference/Journal Club)

Title: Retrospective Study of Misuse of Steroids in Hoarseness of Voice
"Good morning everyone. I'd like to present a retrospective study examining a common but under-recognized clinical problem: the misuse of corticosteroids in patients with hoarseness of voice.
Background: Hoarseness of voice, or dysphonia, is one of the commonest ENT complaints. The causes range from simple acute laryngitis to laryngeal carcinoma. Despite clear AAO-HNS guidelines recommending laryngoscopy before any pharmacological intervention, corticosteroids are frequently prescribed empirically.
What we did: We analyzed 96 patients at a tertiary care centre who had received prior steroid therapy for hoarseness, over an 8-month period. Demographics, prescribing patterns, and videostroboscopy findings were recorded.
Key findings: 64.6% were male; mean age 48.7 years. Steroids were most often prescribed by ENT surgeons (41.7%), followed by GPs (35.4%) and chest physicians (22.9%). Crucially, only 33.3% had any laryngeal diagnosis before treatment was started.
Videostroboscopy revealed that 54.2% of patients had no indication for steroid therapy at all. 28.1% had vocal fold edema or nodules - potentially appropriate targets - and 17.7% showed vocal fold atrophy, suggesting steroid-related harm.
Regarding adverse effects: 12.5% developed fungal laryngitis, 8.3% bilateral striking-zone leukoplakia - a potentially pre-malignant condition - and 10.4% experienced systemic effects.
Take-home message: Unindicated steroid use in hoarseness remains a significant clinical problem, even at specialist level. Every patient with hoarseness lasting more than two weeks must undergo laryngoscopy before any treatment. This is not just a guideline recommendation - it is a patient safety issue.
Thank you."

SECTION 11: 10-MINUTE TEACHING PRESENTATION (Postgraduate Students)

Slide 1 - Title: Retrospective Study of Misuse of Steroids in Hoarseness of Voice
Slide 2 - What is HOV?
  • Define: dysphonia = alteration in voice quality/pitch/loudness/effort impairing communication
  • Epidemiology: common ENT symptom; affects ~30% of population at some point
  • Causes: acute laryngitis, nodules, polyps, GERD, functional, neurological, malignancy
  • Key point: HOV is a SYMPTOM, not a diagnosis
Slide 3 - The Problem
  • Corticosteroids frequently prescribed empirically for HOV
  • Anti-inflammatory rationale: valid in some cases (acute inflammatory laryngitis)
  • But: prescribing without diagnosis = treating a symptom, not a disease
  • AAO-HNS 2018 CPG: Strong recommendation AGAINST routine steroids without laryngoscopy
Slide 4 - Study Design
  • Retrospective, observational, single-centre, 8 months, n=96
  • Patients: all had received prior steroids for HOV
  • Assessment: videostroboscopy (gold standard)
  • Statistics: chi-square + paired t-test
Slide 5 - Who Was Prescribed Steroids? (Table 1 + Fig 1)
  • Male predominance (64.6%); mean age 48.7 years
  • Prescribers: ENT 41.7%, GPs 35.4%, Chest 22.9%
  • Only 33.3% had a prior laryngeal diagnosis - KEY FINDING
Slide 6 - What Did Stroboscopy Show? (Table 2 + Fig 2)
  • 54.2% NO indication for steroids
  • 28.1% edema/nodules (possible indication)
  • 17.7% atrophy (possible steroid-induced harm)
  • Explain stroboscopy technique here
Slide 7 - What Harm Did Steroids Cause? (Table 3 + Fig 3)
  • Fungal laryngitis: 12.5% - iatrogenic, preventable
  • Leukoplakia: 8.3% - pre-malignant potential
  • Systemic: 10.4% - weight gain, gastritis
  • Total harm rate: >30%
Slide 8 - Why Does This Happen?
  • Mechanism of fungal laryngitis: local immunosuppression
  • Mechanism of atrophy: SLP fibroblast suppression, reduced hyaluronate
  • Mechanism of leukoplakia: repeated mucosal irritation + steroid effects on epithelial metabolism
Slide 9 - Guidelines and What They Say
  • AAO-HNS 2018 (PMID 29494321): Laryngoscopy before treatment; no routine steroids
  • Turley & Cohen 2010: >20% GPs prescribe without laryngoscopy
  • Nerurkar 2025: Indian data confirming same pattern
Slide 10 - Clinical Implications and Take-Home
  • Always visualize before prescribing
  • If steroids used: use spacers, recommend mouth rinsing, monitor larynx
  • Fungal laryngitis: treat with antifungals
  • Leukoplakia: biopsy; surveillance
  • Systemic steroids: short course only, with clear indication

SECTION 12: REVISION NOTES - HIGH-YIELD POINTS

STEROID MISUSE IN HOV - HIGH-YIELD SUMMARY

Study: Retrospective, n=96, tertiary care, 8 months

KEY NUMBERS TO REMEMBER:
- 64.6% male, mean age 48.71 years
- 66.7% had NO prior laryngeal diagnosis (misuse marker)
- 54.2% had NO stroboscopic indication (confirmed misuse)
- Prescribers: ENT 41.7% > GP 35.4% > Chest 22.9%
- Adverse effects: Fungal laryngitis 12.5%, Leukoplakia 8.3%, Systemic 10.4%
- Total harm: ~31%

PATHOPHYSIOLOGY:
- Steroids -> local immunosuppression -> Candida laryngitis
- Steroids -> SLP atrophy -> mucosal wave reduction -> worsened dysphonia
- Chronic irritation + steroids -> epithelial keratinization -> leukoplakia

GUIDELINE:
- AAO-HNS 2018: STRONGLY AGAINST routine steroids in HOV
- Laryngoscopy BEFORE any intervention
- HOV >4 weeks (or serious cause suspected at any duration) = mandatory laryngoscopy

TREATMENT OF COMPLICATIONS:
- Fungal laryngitis: Fluconazole or nystatin
- Leukoplakia: Microlaryngoscopy + biopsy + surveillance
- Atrophy: Remove steroids; voice therapy; time

BUZZWORDS: striking zone, mucosal wave, Reinke's space, stroboscopy, SLP atrophy

SECTION 13: FLASHCARDS FOR ACTIVE RECALL

Card 1 Q: What percentage of patients in this study had NO indication for steroid therapy on videostroboscopy? A: 54.2%
Card 2 Q: What does the AAO-HNS 2018 guideline recommend regarding steroids in hoarseness? A: Strong recommendation AGAINST routine corticosteroid prescription for dysphonia without prior laryngoscopy
Card 3 Q: What is the most common adverse effect of misused steroids seen in HOV patients in this study? A: Fungal laryngitis (12.5%)
Card 4 Q: What is the "striking zone" of the vocal fold and why is it significant? A: Mid-membranous free edge of the vocal fold - site of maximum mechanical contact during phonation. Leukoplakia here has pre-malignant potential.
Card 5 Q: What stroboscopic finding in 17.7% of patients suggests steroid-induced harm? A: Vocal fold atrophy / mucosal wave reduction
Card 6 Q: Which specialty most commonly prescribed steroids in this study? A: ENT surgeons (41.7%)
Card 7 Q: Name the three components of Reinke's space (superficial lamina propria). A: Hyaluronic acid (predominant), fibronectin, elastin/collagen fibres
Card 8 Q: What is the treatment for steroid-induced fungal laryngitis? A: Antifungal therapy - Fluconazole (150mg weekly x4 weeks or 100-200mg daily x2 weeks) or Nystatin suspension for mild cases
Card 9 Q: What percentage of patients had a prior laryngeal diagnosis before steroid prescription? A: Only 33.3% (i.e., 66.7% had NO prior diagnosis)
Card 10 Q: Stroboscopy creates apparent slow-motion by doing what? A: Synchronizing strobe light frequency just slightly out of phase with the fundamental frequency of vocal fold vibration

SECTION 14: MCQs AND CLINICAL SCENARIO-BASED QUESTIONS

MCQs

MCQ 1. A 52-year-old male presents with hoarseness of voice for 6 weeks. His GP prescribed a 2-week course of oral prednisolone. Which investigation should have been performed BEFORE this prescription? A) CT chest B) MRI neck C) Laryngoscopy/videostroboscopy D) Thyroid function tests
Answer: C Explanation: AAO-HNS 2018 CPG mandates laryngoscopy before prescribing corticosteroids for dysphonia. HOV >4 weeks warrants visualization regardless. CT/MRI should not precede laryngoscopy as a first-line investigation.
MCQ 2. In the above retrospective study, which prescribing specialty prescribed steroids most frequently for HOV? A) General physicians B) Chest physicians C) ENT surgeons D) Internal medicine physicians
Answer: C - ENT surgeons (41.7%) Explanation: Counterintuitively, ENT surgeons - who have access to laryngoscopy - prescribed the highest proportion. This highlights that empirical prescribing occurs even at specialist level.
MCQ 3. A patient on long-term inhaled corticosteroids for asthma develops white patches on both vocal folds at the mid-membranous area. What is the MOST appropriate next step? A) Prescribe systemic antifungals empirically B) Stop inhaled steroids immediately C) Microlaryngoscopy and biopsy D) Voice therapy alone
Answer: C Explanation: Bilateral striking-zone leukoplakia requires biopsy to rule out dysplasia or carcinoma in situ. Management is not solely medical.
MCQ 4. Videostroboscopy showed mucosal wave reduction in 17.7% of patients in this study. The MOST likely cause is: A) Undetected laryngeal carcinoma B) Steroid-induced superficial lamina propria atrophy C) Vocal fold paralysis D) GERD-related subglottic edema
Answer: B Explanation: Prolonged corticosteroids suppress fibroblast activity and reduce hyaluronate synthesis in Reinke's space, causing mucosal atrophy and reduced wave propagation. This is an iatrogenic finding.
MCQ 5. Which statistical test was used to compare pre- and post-stroboscopy findings in this study? A) Chi-square test B) Mann-Whitney U test C) Paired t-test D) Fisher's exact test
Answer: C Explanation: Paired t-test compares two related measurements in the same subjects (pre- vs post-). Chi-square was used for categorical data comparisons between groups.

Clinical Scenario

Scenario: A 45-year-old male school teacher presents to the ENT OPD with hoarseness of voice for 8 weeks. He was started on oral methylprednisolone by a GP 4 weeks ago with no improvement. He is a non-smoker, no significant medical history. On examination, indirect laryngoscopy reveals white patches bilaterally at the mid-membranous vocal folds with surrounding erythema.
Questions:
  1. What is the most likely diagnosis and its etiology? Answer: Bilateral striking-zone leukoplakia with probable superimposed Candida laryngitis, induced by corticosteroid misuse without prior diagnosis. The white patches at the striking zone are consistent with steroid-induced epithelial changes ± fungal colonization.
  2. What investigation should have been done before steroid prescription? Answer: Videostroboscopy (or at minimum, flexible/rigid laryngoscopy) as per AAO-HNS 2018 guidelines. This would have identified the original cause of HOV and prevented empirical steroid use.
  3. What is your immediate management plan? Answer: (1) Stop oral corticosteroids; (2) KOH mount / fungal culture from laryngeal swab; (3) Start antifungal - fluconazole 150mg weekly for 4 weeks; (4) Schedule microlaryngoscopy under GA for biopsy of leukoplakic patches; (5) Exclude malignancy histologically; (6) Investigate and treat underlying cause of original HOV (laryngoscopy-directed approach); (7) Voice therapy if needed; (8) Regular follow-up with serial laryngoscopy.
  4. What is the pre-malignant potential of striking-zone leukoplakia? Answer: Malignant transformation rates for vocal fold leukoplakia vary by histological grade: simple hyperkeratosis <1%; mild dysplasia ~3-5%; moderate-severe dysplasia 10-30%; carcinoma in situ 15-40%. Biopsy is mandatory for histological grading to guide management and follow-up intervals.

SECTION 15: CLINICAL IMPLICATIONS AND PATIENT MANAGEMENT IMPACT

FindingClinical Implication
54.2% had no stroboscopic indicationMandatory pre-prescription laryngoscopy would have prevented steroid use in over half the patients
66.7% no prior laryngeal diagnosisSystem-level change needed: GP referral pathways, ENT specialist practice change
12.5% fungal laryngitisAdds morbidity, prolongs treatment course, requires antifungals, increases cost
8.3% leukoplakiaRequires biopsy + long-term surveillance; may require surgical intervention; carries malignant risk
10.4% systemic effectsWeight gain, gastritis add further morbidity; relevant in diabetic and hypertensive patients
Male predominance (64.6%)Male patients with HOV need particular vigilance for laryngeal carcinoma - a key differential not to be masked by steroids
Mean age 48.7 yearsPeak risk age for laryngeal carcinoma; empirical steroid use in this demographic is especially dangerous as it can delay cancer diagnosis
Most Important Implication: Empirical steroids in HOV can mask laryngeal carcinoma by transiently reducing inflammatory edema around a tumor, providing false reassurance and delaying diagnosis. This is the most serious patient safety concern, and is why the AAO-HNS guideline is unequivocal.

SECTION 16: LIMITATIONS OF THE STUDY

  1. Retrospective design: Cannot establish causality; recall and selection bias possible.
  2. Single-centre data: Results may not be generalizable to other settings.
  3. No control group: No comparison with steroid-naive HOV patients to quantify the attributable risk of steroids.
  4. Duration of steroid use not stratified: Dose-response relationship between steroid duration/dose and adverse effects not analyzed.
  5. Confounders not controlled: Smoking, GERD, LPR, alcohol, and voice use habits could independently cause leukoplakia and mucosal changes.
  6. Causality of leukoplakia uncertain: Cannot prove steroids caused leukoplakia vs. pre-existing pathology.
  7. Small sample (n=96): Limits statistical power for subgroup analyses.
  8. Follow-up not stated: Duration of follow-up for adverse effects and resolution not reported.
  9. Blinded authors: Cannot verify the primary data or institutional context.
  10. Prescribing indication not validated: Prescribers' reasoning for steroid use not captured.

SECTION 17: WHAT CANNOT BE DETERMINED FROM THIS POSTER

  • Author names and institution (blinded for competition)
  • Specific drugs prescribed (oral prednisolone vs. dexamethasone vs. inhaled steroids)
  • Dose and duration of steroid use
  • Original underlying cause of HOV in each patient
  • Whether patients with fungal laryngitis were subsequently cured
  • Long-term follow-up outcomes, especially for leukoplakia patients
  • Whether malignancy was excluded in all patients
  • Smoking and alcohol history of patients
  • Whether prior laryngeal diagnosis was done elsewhere (only 33.3% at this centre)

MASTER SUMMARY

ONE-PAGE MASTER SUMMARY

Retrospective Study of Misuse of Steroids in Hoarseness of Voice

Study type: Retrospective observational | n=96 | Tertiary care, 8 months | Ethics approved

CORE PROBLEM

Corticosteroids are frequently prescribed for hoarseness of voice (HOV = dysphonia) without prior laryngoscopy, violating AAO-HNS 2018 guidelines. This study quantifies this misuse and its consequences in a tertiary care Indian population.

KEY NUMBERS

ParameterValue
Male predominance64.6%
Mean age48.71 ± 12.46 years
NO prior laryngeal diagnosis66.7% (core misuse metric)
Prescribed by ENT41.7% (highest)
NO stroboscopic indication for steroids54.2%
Edema/nodules (possible indication)28.1%
Atrophy/wave reduction (possible harm)17.7%
Fungal laryngitis (adverse effect)12.5%
Leukoplakia (adverse effect)8.3%
Systemic effects10.4%

PATHOPHYSIOLOGY IN 3 LINES

  • Steroids -> local immunosuppression -> Candida laryngitis (12.5%)
  • Steroids -> SLP (Reinke's space) atrophy -> mucosal wave reduction (17.7%)
  • Chronic irritation + steroids -> epithelial keratinization -> striking-zone leukoplakia (8.3%, pre-malignant)

CRITICAL GUIDELINE

AAO-HNS 2018 CPG (Stachler et al., PMID 29494321): Strong recommendation AGAINST routine steroids in HOV. Laryngoscopy/videostroboscopy MUST precede all treatment. HOV >4 weeks = mandatory laryngoscopy.

WHAT IS VIDEOSTROBOSCOPY?

Stroboscopic light synchronized just out-of-phase with vocal fold vibration frequency -> apparent slow-motion -> assesses mucosal wave, glottal closure, symmetry, lesion effects. Gold standard for HOV assessment.

ADVERSE EFFECTS AND MANAGEMENT

ComplicationManagement
Fungal laryngitisFluconazole 150mg weekly x4 weeks OR Nystatin
LeukoplakiaMicrolaryngoscopy + biopsy + surveillance (malignant risk)
Systemic (weight gain, gastritis)Withdraw steroids; symptomatic management
Mucosal atrophyStop steroids; voice therapy; time

TOP 5 LEARNING POINTS

  1. HOV is a symptom, not a diagnosis - never prescribe empirically
  2. 66.7% had no prior diagnosis; 54.2% had no indication - clear misuse
  3. 30% suffered measurable steroid-related harm
  4. Even ENT specialists were the most frequent offenders (41.7%)
  5. Laryngoscopy before ANY intervention is non-negotiable (patient safety: masks malignancy)

VIVA PEARLS

  • "Striking zone" = mid-membranous free edge, maximum contact area, site of leukoplakia
  • "Reinke's space" = SLP, loosely organized ECM, site of edema AND steroid-induced atrophy
  • Stroboscopy shows mucosal wave - best indicator of vocal fold pliability
  • Fungal laryngitis = Candida; treat with fluconazole (systemic azole)
  • Leukoplakia: ALWAYS biopsy; rule out dysplasia/CIS/SCC

REFERENCES TO CITE

  1. Stachler RJ et al. AAO-HNS CPG Hoarseness Update 2018. PMID 29494321
  2. Nerurkar NK et al. Indian J Otolaryngol Head Neck Surg. 2025;77(6):2370-4
  3. Schwartz SR et al. Otolaryngol Head Neck Surg. 2009 (original CPG). PMID 19729111
  4. Turley R, Cohen S. Otolaryngol Head Neck Surg. 2010;142(3):310-4
  5. Spiegel JR et al. Otolaryngol Clin North Am. 2000;33(4):771-84
"Appropriate laryngeal assessment before steroid prescription is essential to reduce unnecessary exposure and prevent complications - particularly fungal laryngitis." (Conclusion, Poster)
This master summary contains everything needed to understand, revise, answer viva questions, and present this poster. No further reference to the image is required.

1,2

Asking for Preferences

Last 4 options were there out of which i choose 1,2 that is visual flow chart and high yield 10 images

Generating Image

Medical educational flowchart titled "Management of Hoarseness of Voice (HOV) - Avoiding Steroid Misuse". Clean clinical flowchart with boxes and arrows. Flow: Patient presents with Hoarseness of Voice → Assessment: Duration >2 weeks? → YES → Laryngoscopy / Videostroboscopy MANDATORY (AAO-HNS 2018) → Findings branch into 4 paths: (1) Normal/No lesion → No steroids, investigate other causes; (2) Vocal fold edema/nodules → Voice therapy ± short-course steroids with monitoring; (3) Atrophy/Mucosal wave reduction → Stop steroids, voice therapy; (4) Leukoplakia → Microlaryngoscopy + Biopsy → Histology grading → Surveillance. Side box: "Complications of empirical steroids: Fungal laryngitis 12.5%, Leukoplakia 8.3%, Systemic effects 10.4%". Bottom warning box in red: "NEVER prescribe corticosteroids for HOV without prior laryngoscopy". Professional medical poster style, white background, color-coded boxes, clear arrows.

Generating Image

High-yield medical education image: Anatomy of the normal human larynx and vocal folds viewed from above (laryngoscopic view). Detailed anatomical diagram showing: true vocal folds (white, pearlescent), false vocal folds, arytenoid cartilages, epiglottis, subglottis, anterior commissure, posterior commissure, mid-membranous striking zone labeled with arrow. Labels clearly pointing to each structure. Title: "Normal Laryngoscopic Anatomy". Clean medical illustration style on white background.

Generating Image

Medical education diagram: Mechanism of corticosteroid-induced harm to vocal folds. Split diagram showing LEFT side "Normal Vocal Fold" with healthy Reinke's space (superficial lamina propria) containing hyaluronic acid, fibronectin, elastin labeled, showing normal mucosal wave with curved arrows. RIGHT side "After Prolonged Steroids" showing: atrophied Reinke's space, reduced hyaluronate, suppressed fibroblasts, flattened mucosal wave labeled as "reduced/absent". Center arrows showing the process: Corticosteroids → suppress fibroblasts → reduce hyaluronate synthesis → SLP atrophy → impaired mucosal wave → dysphonia worsens. Clean medical illustration, labeled, professional, white background.

Generating Image

Medical education diagram: Pathogenesis of steroid-induced fungal laryngitis. Step-by-step infographic. Step 1: Corticosteroids (systemic or inhaled) administered. Step 2: Local immunosuppression - reduced mucosal IgA, impaired cell-mediated immunity, reduced mucociliary clearance. Step 3: Candida albicans (yeast illustration) overgrowth on laryngeal mucosa. Step 4: White pseudomembranous plaques on vocal folds (laryngoscopic view illustration). Step 5: Treatment - Fluconazole / Nystatin → Resolution. Prevention box: "Use spacer devices, gargle after inhaler use". Color-coded steps, medical illustration style, clean white background, educational poster format.

Generating Image

Medical education diagram: Videostroboscopy - How it works. Visual explanation showing: (1) Vocal folds vibrating at 200 Hz (too fast for eye). (2) Strobe light flashing at 199 Hz (just out of phase). (3) Brain perceives apparent slow motion at 1 Hz. Diagram of stroboscope device, light beam, larynx cross-section. Parameters assessed listed in sidebar: Mucosal wave, Glottal closure, Vibratory symmetry, Phase closure, Non-vibrating portions. Bottom: Clinical significance - "Gold standard for vocal fold assessment before any intervention". Medical illustration, educational, clean white background, labeled arrows, professional style.

Generating Image

Medical education diagram: Vocal fold leukoplakia progression - spectrum from normal to malignancy. Horizontal timeline with 5 stages showing laryngoscopic appearance and histology side by side: Stage 1 Normal vocal fold (white, smooth), Stage 2 Hyperkeratosis (slightly thickened white patch), Stage 3 Mild-Moderate Dysplasia (irregular white patch, erythema), Stage 4 Severe Dysplasia / CIS (thick irregular leukoplakia with erythema), Stage 5 Invasive SCC (irregular exophytic lesion). Malignant transformation risk percentages labeled under each stage: <1%, 3-5%, 10-20%, 30-40%, 100%. Red arrow showing "BIOPSY MANDATORY" pointing to all stages from Stage 2. Title: "Striking-Zone Leukoplakia: Histological Spectrum". Medical illustration, labeled, professional, white background.

Generating Image

Medical education infographic: "Key Statistics from Retrospective Study of Steroid Misuse in HOV". Visual data summary with icons and numbers. Large bold numbers with labels: 96 patients studied, 64.6% Male, 48.71 years mean age, 66.7% had NO prior laryngeal diagnosis (highlighted in red), 54.2% NO stroboscopic indication for steroids (highlighted in orange), 12.5% Fungal laryngitis (complication), 8.3% Leukoplakia (complication), 10.4% Systemic effects. Bar chart at bottom showing prescribers: ENT 41.7%, GP 35.4%, Chest 22.9%. Title at top in bold. Clean infographic style, color-coded, professional medical design, white background.

Generating Image

Medical education diagram: Causes of Hoarseness of Voice - classification wheel/mind map. Central circle labeled "Hoarseness of Voice (Dysphonia)". Six branches radiating outward: (1) Structural - nodules, polyps, Reinke's edema, cysts, papilloma, carcinoma; (2) Inflammatory - acute laryngitis, chronic laryngitis, GERD/LPR, fungal laryngitis; (3) Neurological - vocal fold palsy (RLN injury), spasmodic dysphonia, Parkinson's; (4) Functional - muscle tension dysphonia, psychogenic dysphonia; (5) Systemic - hypothyroidism, rheumatoid arthritis (cricoarytenoid); (6) Iatrogenic - steroid-induced atrophy, post-surgical, post-intubation. Each branch color-coded differently. Small icons for each category. Title: "Differential Diagnosis of HOV". Professional medical illustration, white background.

!

429 Too Many Requests. {'message': '{\n "error": {\n "code": 429,\n "message": "Resource exhausted. Please try again later. Please refer to https://cloud.google.com/vertex-ai/generative-ai/docs/error-code-429 for more details.",\n "status": "RESOURCE_EXHAUSTED"\n }\n}\n', 'status': 'Too Many Requests'}

We encountered an error while processing your request. Please try again or reach out to us for help.

🔗Contact Support
✉️hi@orris.care
This is a shared conversation. Sign in to Orris to start your own chat.